#1 out of 40.00%
health2h ago
Weight-loss jabs could halve sickness absence and ease strain on NHS, study suggests
- UK study shows GLP-1 weight-loss injections cut sick days by 45% over nine months.
- Long-term absences dropped by more than half, easing NHS staffing pressures.
- GP visits and in-person appointments declined as patients used digital care.
- Experts say expanding access to anti-obesity meds could cut A&E visits by a quarter.
- NHS could save about £364 million annually by widening jab eligibility.
- Study involved 1,270 NHS patients on Oviva’s tier 3 weight-management programme.
- Wegovy and Ozempic users achieved ~12.4% weight loss after nine months.
- Danish studies linked GLP-1 use to fewer asthma exacerbations and migraine relief.
- Researchers note the effects appear soon after starting GLP-1 therapy, even before weight loss.
Vote 0



